Christopher Huntington

Statistics

Publications

Citations

132

H-Index

Active since

2010

Affiliations

AstraZeneca (United States)(Current)

Christopher Huntington is an author at AstraZeneca (United States) specializing in inhibitor of apoptosis proteins, cancer pharmacology, and iap antagonists.

Publications per year

2010–2013

Publications

Discovery of a Novel Class of Dimeric Smac Mimetics as Potent IAP Antagonists Resulting in a Clinical Candidate for the Treatment of Cancer (AZD5582)

Edward J. Hennessy, Ammar Adam, Brian Aquila et al. · Journal of Medicinal Chemistry · 2013 · 115 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Use of high‐resolution mass spectrometry to investigate a metabolite interference during liquid chromatography/tandem mass spectrometric quantification of a small molecule in toxicokinetic study samples

Michael Furlong, Andrew J. Bessire, Wei Song et al. · Rapid Communications in Mass Spectrometry · 2010 · 17 citations

Pharmacy, Toxicology, Analytical Chemistry +15

1–2 of 2